Dupuytren Contracture Clinical Trial
Official title:
A Prospective Clinical Trial of Radiation Therapy for Dupuytren's Contracture Following Surgical and Non-Surgical Release
The goal of this study is to learn about preventing recurrence of Dupuytren's Contracture. The main question it aims to answer are: • Does targeted radiation therapy decrease recurrence of Dupuytren's contracture after treatment with Collagenase Clostridium Histolyticum? Participants will undergo: - Release of Dupuytren's Contracture after Collagenase Clostridium Histolyticum injection - Daily radiation therapy treatment for 5 days followed by 6-8 week rest period and then another course of 5 days of radiation therapy
This is a prospective phase II trial where patients diagnosed with late/advanced stage Dupuytren's Contracture (DC) who undergo successful Collagenase Clostridium Histolyticum (CCH) injection and release will receive a standardized regimen of adjuvant radiotherapy (RT). The study will be powered to assess the outcome in patients undergoing the combination of successful release followed by RT. Patients will be monitored for acute and late toxicities while we evaluate disease recurrence defined as a > 20 degree worsening of contracture in the presence of a palpable cord as compared to within 14 days from CCH injection, or the need for medical/surgical intervention to correct the new or worsening contracture. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03155854 -
The Effects of Prophylactic Limited Palmar Fasciectomy on Surgical Outcomes and Scarring
|
N/A | |
| Active, not recruiting |
NCT03192020 -
Trial Comparing Treatment Strategies in Dupuytren's Contracture
|
Phase 4 | |
| Recruiting |
NCT05300893 -
Effectiveness of Night Splinting After Percutaneous Needle Fasciotomy in Dupuytren's Contracture
|
N/A | |
| Completed |
NCT02647619 -
Dupuytren´s Disease Study. Primary Disease, MCP Joint, Xiapex, PNF
|
Phase 4 | |
| Recruiting |
NCT01184586 -
Dupuytren's Disease and Extracorporeal Shockwave Therapy (DupuyShock-2010)
|
Phase 2 | |
| Recruiting |
NCT04122313 -
Post-contracture Release Radiation for Dupuytren's Disease
|
||
| Withdrawn |
NCT01776892 -
Collagenase and Needle Aponeurotomy: Single Modality Versus Combination Treatment for Dupuytren's Disease
|
Phase 3 | |
| Completed |
NCT02983162 -
Is wGRS Associated With DD Recurrence?
|
||
| Completed |
NCT01923103 -
Natural Disease Progress of Dupuytren Disease
|
||
| Enrolling by invitation |
NCT03982719 -
Comparing the Effectiveness of Two Post-fasciectomy Rehabilitation Protocols in Patients With Dupuytren's Disease
|
N/A | |
| Not yet recruiting |
NCT04907812 -
The Role of Tranexamic Acid in Reducing Post Operative Hand Edema After Hand and Wrist Surgery
|
Phase 4 | |
| Withdrawn |
NCT03031080 -
BOND Study: the Benefit Of Night Splinting in Dupuytrens'
|
N/A | |
| Completed |
NCT04874870 -
Effectiveness of Splinting After Collagenase Injection
|
Phase 3 | |
| Active, not recruiting |
NCT03407820 -
Different Sutures in Hand Surgery
|
N/A | |
| Recruiting |
NCT03000114 -
Collagenase Injection vs Percutaneous Needle Aponeurotomy for Dupuytren's Disease
|
Phase 4 | |
| Recruiting |
NCT05440240 -
Percutaneous Needle Fasciotomy +/- Corticosteroid Injection for Dupuytren's Contracture
|
Phase 4 | |
| Completed |
NCT03331926 -
Collagenase is a Common Treatment of MCP and PIP Joint Contractures in Dupuytrens Disease
|
||
| Active, not recruiting |
NCT03741764 -
Treatment of Dupuytren's Disease With Minimal Invasive Surgery and VIVOSORB® Resorbable Implant Device
|
N/A | |
| Completed |
NCT01876498 -
Registry of Patient With M. Dupuytren and Validation of the Brief MHQ
|
N/A | |
| Completed |
NCT03868449 -
Question Prompt List for Common Hand Conditions
|
N/A |